Cleome innovations operates at the intersection of electronics, biology and data science, to translate deep-tech research into next-generation adaptive, affordable and accessible Diagnostic solutions
Sanket Goel, Founding Director
India’s MedTech startup ecosystem is undergoing a profound transformation, fueled by the convergence of healthcare needs, technological innovation, and policy support. Startups across the country are redefining how diagnostics and treatment are delivered, shifting from centralized, infrastructure-heavy systems to agile, patient-centric models.
This evolution is particularly critical in a nation where access, affordability, and speed remain key challenges. Emerging companies are leveraging biosensing, artificial intelligence, and microfluidics to bring diagnostics closer to patients, whether in clinics, ICUs, or homes.
At the forefront of this shift is Cleome Innovations, a deep-tech startup that is reimagining diagnostics through integrated, implementable, and intelligent platforms designed for real-world healthcare environments.
Cleome Innovations operates at the intersection of electronics, biology and data science, to translate deep-tech research into next-generation adaptive, affordable and accessible diagnostic solutions. The company is driven by a clear vision: to transition diagnostics from a reactive, lab-dependent process to a proactive and decentralized system.
This shift is particularly relevant in India, where delayed test results and limited access to advanced diagnostics often hinder timely clinical decisions.
By developing point-of-care diagnostic platforms, Cleome is enabling faster and more efficient healthcare delivery. Its solutions are designed to function beyond traditional laboratories, bringing high-quality diagnostics directly to clinical settings and underserved regions.
This approach not only reduces turnaround times but also empowers healthcare providers with immediate, actionable insights, an essential factor in critical care and infectious disease management.
Addressing Systemic Healthcare Challenges
Healthcare providers in India continue to face several structural challenges, including reliance on centralized labs, high equipment costs, and limited diagnostic access in Tier 2 and Tier 3 cities. Cleome Innovations has positioned itself to directly address these gaps through its integrated and portable diagnostic systems.
The company’s platforms are engineered to minimize dependence on large laboratory infrastructure while maintaining high sensitivity and accuracy. By focusing on usability and deployment flexibility, Cleome ensures that its technologies can operate effectively across diverse healthcare settings.
More importantly, its solutions emphasize delivering clinically actionable results rather than raw data, enabling doctors to make faster and more informed decisions.
This approach aligns with broader industry trends where diagnostics are becoming increasingly decentralized and technology-driven. With rising awareness of early disease detection and a growing burden of infectious and chronic diseases, the demand for rapid, reliable, and cost-effective diagnostic tools is only expected to increase.
Cleome innovations operates at the intersection of electronics, biology and data science, to translate deep-tech research into next-generation adaptive, affordable and accessible Diagnostic solutionsSanket Goel, Founding Director
Platform-Based Technology and Core Offerings
A key differentiator for Cleome Innovations lies in its platform-based approach. Instead of developing single-use diagnostic devices, the company builds modular technologies that can be adapted across multiple applications. This not only enhances scalability but also significantly reduces development time and cost when addressing new diagnostic needs.
At the core of its offerings are electrochemical biosensing systems and microfluidic-enabled diagnostic devices. These technologies enable rapid detection with minimal sample volumes and faster processing times. Such integration allows for high precision while maintaining affordability, an essential balance in the Indian healthcare context.
One of Cleome’s most notable achievements is its work on an integrated diagnostic platform for Antimicrobial Resistance (AMR) and Antimicrobial Susceptibility Testing (AST).
This solution combines advanced sensing technologies with intelligent data analysis to deliver results in significantly reduced timeframes compared to conventional methods.
Importantly, the underlying architecture of this platform is modular, allowing it to be extended to other infectious diseases and diagnostic applications, reinforcing the company’s commitment to scalable innovation.
Leveraging AI and Building for the Future
Cleome Innovations is also actively incorporating artificial intelligence and automation into its platforms to enhance diagnostic accuracy and accessibility. AI-driven analytics enable pattern recognition and predictive insights, while automated workflows reduce human error and variability.
The integration of digital connectivity further allows for real-time data sharing and remote monitoring, paving the way for more connected and responsive healthcare systems.
Regulatory readiness is another area where Cleome demonstrates foresight. By adopting a compliance-by-design approach, the company integrates regulatory requirements early in its development cycle.
Alignment with CDSCO guidelines and international standards, coupled with strong validation protocols, ensures that its products meet stringent safety and reliability benchmarks while accelerating time to market.
The company’s growth journey reflects its strong innovation foundation. Supported by the Biotechnology Ignition Grant (BIG) from BIRAC and recognized with the IEEE India Council’s “Technology Start-up of the Year” award in 2024, Cleome has steadily progressed from research to real-world application.
Its incubation at BITS Pilani Hyderabad Campus and collaborations with academic and healthcare institutions have further strengthened its ecosystem.
Looking ahead, Cleome Innovations aims to lead the development of intelligent, decentralized diagnostic platforms not just in India but globally. With a focus on scaling technologies, expanding into new diagnostic domains, and integrating with digital health ecosystems, the company is well-positioned to shape the future of diagnostics.
As the industry continues to evolve, the convergence of diagnostics, data, and decision-support systems will define the next frontier - one that Cleome Innovations is already actively building toward.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")